ABBVIE A/S

CVR: 34462828

Stable revenueMedium companyWell-established (13 yrs)Profitable

Secondary names: Allergan Aesthetics A/S

Active

ABBVIE A/S demonstrates a solid financial health with a consistent revenue growth trajectory, increasing from 183.9 million DKK in 2020 to 336.9 million DKK in 2024. However, profit margins have shown some volatility, with a peak profit of 13.7 million DKK in 2023, followed by a decline to 11.1 million DKK in 2024. The company's equity has decreased significantly from 196.2 million DKK in 2022 to 72.9 million DKK in 2024, raising concerns about its long-term financial stability. Positioned within the wholesale trade of medical and hospital supplies, ABBVIE A/S is navigating a competitive landscape, and its ability to maintain profitability amidst fluctuating equity will be crucial for future growth.

AI-generated summary

Overview

Company type: A/S; Aktieselskab
Address: Titangade 11, 2200 København N; KØBENHAVN; 2200 København N; Find nearby companies
Founded: 14.3.2012

Details

Industry: Engroshandel med læge- og hospitalsartikler; Code: 464620
Employees: 88 employees; 76 FTE; (2018)
Capital: 501.000 kr.

Purpose

Selskabets formål er at drive handel med farmaceutiske produkter, hospitalsprodukter og diagnostik samt udvikle, producere og markedsføre teknologi og know-how i forbindelse hermed. Selskabet kan derudover yde tjenesteydelser og assistance, herunder af administrativ, driftmæssig, finansiel, forretningsmæssig, videnskabelig eller industriel karakter, i tilknytning til selskabets formål til tredjemænd, aktionærer, datterselskaber eller tilknyttede selkaber.